Is the 10,000-steps-per-day target based on evidence?

Not originally. The number comes from a 1965 Japanese pedometer marketed as 'manpo-kei' (10,000-step meter) — a commercial name, not a clinical trial result. Research has since shown that mortality benefit increases steeply from low baselines and levels off at an age-dependent ceiling: around 6,000–8,000 steps per day for adults over 60, and 8,000–10,000 for adults under 60, per a 2022 Lancet Public Health meta-analysis of 47,471 people across 15 cohorts. That said, 10,000 makes a reasonable stretch goal for younger adults. The key message is that any increase from a sedentary baseline produces benefit — you do not need to reach 10,000 before the walking counts.

Does walking speed matter or is total step count all that matters?

Both matter independently. Step volume drives most of the benefit, but cadence — walking speed — adds additional cardiovascular gain beyond what step count alone predicts. Walking at or above 100 steps per minute corresponds to moderate-intensity exercise and appears to independently lower mortality and chronic-disease risk. Practically, this means aiming for at least one 30-minute brisk walk daily (where you can speak in sentences but not sing comfortably) in addition to accumulating total daily steps. Brisk short bouts — stairs, rapid laps, a brisk walk between tasks — also count and have been shown to meaningfully reduce mortality in non-exercising adults.

What step target is right for an older adult?

For adults aged 60–79, the evidence suggests a target of 6,000–8,000 steps per day, with a brisk cadence where tolerated. For adults aged 80 and over, or for frail individuals, 4,000–6,000 steps per day still provides mortality benefit, and the focus shifts more toward safety and balance than speed. The Australian 24-Hour Movement Guidelines (updated 2026) recommend 7,000 steps per day as a trackable target for most adults. For older adults at falls risk, it is important to pair walking with strength and balance training — brisk walking alone does not reduce falls risk as effectively as combined exercise.

Can walking help with depression or anxiety?

Yes — moderate-intensity walking has clinically meaningful effects on mood and anxiety. Aerobic exercise including brisk walking is recommended as an adjunct treatment for mild-to-moderate depression and anxiety in Australian general practice guidelines. The mechanism involves BDNF-driven neurogenesis, improved sleep, reduced inflammatory markers, and psychosocial benefits from getting outdoors and interacting with others. Walking in greenspace (parks, bushland, waterways) appears to amplify the mood effect compared with urban footpaths. A mental health care plan (MBS items 2715 and 2717) can include referral to a psychologist who incorporates behavioural activation — structured, supported walking as part of depression management.

Are there situations when walking should be limited or avoided?

Yes. Walking should be deferred or limited in unstable coronary artery disease, decompensated heart failure, unstable arrhythmias, active DVT, recent pulmonary embolism, severe peripheral arterial disease with rest pain, a febrile illness, or a significant acute musculoskeletal injury limiting gait. For anyone with a recently diagnosed cardiac condition, a confirmed arrhythmia, or exertional symptoms such as chest tightness or dizziness, a GP review before resuming or escalating walking is appropriate. During flu or COVID-19 illness, rest for the acute phase and return gradually — there is a theoretical risk of myocarditis with high-intensity exercise within two to four weeks of systemic viral illness.

How can I track steps accurately and which apps or devices work?

Modern wrist-worn devices — Apple Watch, Garmin, Fitbit — are validated within approximately 5–10% accuracy at normal walking speeds and are the most practical option for most people. Smartphone step-counting apps (Apple Health, Google Fit, Samsung Health) work when the phone is on your person but may undercount if it stays in a bag. Manual pedometers clipped to the waistband are accurate within 5–10% and cost as little as AU$15–40, making them useful for older adults or those without smartphones. Research-grade waist accelerometers are the reference standard used in the major studies but are not available clinically. For frail older adults or those with shuffle gaits, wrist devices may overcount or undercount — a waist-clip pedometer is more reliable in this group.

Physical inactivity — exercise prescription

Walking as medicine: step targets, cadence, and the 10,000-step myth

By Dr HB Lo, FACRRM Reviewed 24 October 2026 10 min read

Walking's mortality benefit is steep at low doses: just 2,500 steps per day confers meaningful reduction in all-cause mortality over a sedentary baseline. Benefit accumulates to age-banded ceilings — 7,000–10,000 steps for adults under 60, 6,000–8,000 for those aged 60–79, and 4,000–6,000 for those aged 80 or over.

Cadence matters alongside volume. Walking at 100 steps per minute or faster meets moderate intensity and adds cardiovascular benefit beyond slow daily steps alone. Even three-to-four minutes of brisk walking accumulated in short daily bouts reduces all-cause mortality by around 40% in previously inactive adults.

Walking is the most accessible form of physical activity available to most Australians — requiring no equipment, no fee, and no special training. It is also one of the most rigorously studied. A 2022 meta-analysis published in The Lancet Public Health by Paluch and colleagues pooled data from 47,471 adults across 15 international cohorts and found that mortality benefit begins at as few as 2,500 steps per day compared with a sedentary baseline, increases progressively to an age-dependent ceiling, and does not require vigorous sport or structured gym attendance.

Yet most Australians are familiar only with the “10,000 steps” target — a number that originated not from a clinical trial but from the name of a Japanese pedometer marketed in 1965. The evidence-based picture is richer, more nuanced, and more achievable than that marketing shorthand suggests: the dose that matters is age-appropriate, and cadence — how briskly you walk — adds meaningful cardiovascular benefit independently of how many steps you accumulate.

A. Core clinical — the AU general-practice framework

Physiological rationale

Walking produces its mortality and disease-prevention benefits through several mechanisms operating simultaneously. Moderate-intensity aerobic conditioning improves cardiac stroke volume, promotes mitochondrial biogenesis in skeletal muscle, enhances endothelial nitric-oxide bioavailability, improves lipid and glycaemic profiles, and reduces visceral adiposity through non-exercise activity thermogenesis. These adaptations are achievable at brisk walking intensity — no running is required.

Erickson and colleagues’ 2011 PNAS study randomised 120 sedentary older adults to one year of brisk walking (40 minutes, three times per week) or stretching. The walking group showed a 2% increase in anterior hippocampal volume — reversing approximately one to two years of age-related hippocampal atrophy — alongside measurable spatial memory gains. This finding underpins walking’s role as an evidence-based strategy for reducing dementia risk.

What constitutes moderate-intensity walking

Tudor-Locke and colleagues’ 2018 BJSM consensus paper established that 100 steps per minute is a practical threshold for moderate-intensity walking in adults. This cadence corresponds approximately to a pace where a person can speak in full sentences but cannot comfortably sing — the classic “talk test.” The practical implication for prescribing walking is that cadence should be discussed alongside step count.

Equipment-free ways to find moderate-intensity cadence:

Music at 160 BPM tends to entrain stride at approximately 100 steps per minute
Counted cadence: 25 steps in 15 seconds equals 100 steps per minute
Talk test: complete sentences with mild breathing effort; unable to sing comfortably

Age-banded step targets

The Paluch 2022 meta-analysis, Lee et al. 2019 JAMA Intern Med, and the Australian 24-Hour Movement Guidelines (updated March 2026) collectively support the following age-banded targets:

Age group	Daily step target	Cadence recommendation
Adults under 60	7,000–10,000 steps	≥100 steps/min for ≥30 min daily
Adults 60–79	6,000–8,000 steps	≥100 steps/min where tolerated
Adults 80+ or frail	4,000–6,000 steps	Self-paced; safety and balance prioritised
Cardiac rehab (Phase III)	Progress 3,000 to 6,000+ over 8–12 weeks	Per accredited exercise physiologist prescription

The 7,000-step companion target in the AU 2026 guidelines applies as a trackable goal for adults using wearables or pedometers. It represents the midpoint of the evidence-based range for adults under 60 and is achievable with 30–45 minutes of purposeful walking added to ordinary daily movement.

Vigorous intermittent lifestyle physical activity

Stamatakis and colleagues’ 2022 Nature Medicine study used UK Biobank wearable data from 25,241 non-exercising adults and found that accumulating just three to four minutes per day of vigorous intermittent lifestyle physical activity (VILPA) — short one-minute bursts of brisk walking during daily tasks — was associated with a 38–40% reduction in all-cause mortality and a 48–49% reduction in cardiovascular mortality. This finding is particularly relevant for time-poor patients who cannot commit to structured exercise sessions: adding brisk stair climbing, rapid outdoor laps, or vigorous pace between tasks contributes meaningfully to health outcomes.

B. The dose-response evidence — what the trials show

Key trials in brief

Paluch 2022 (Lancet Public Health, n=47,471): Mortality risk fell progressively above ~2,500 steps per day. The plateau in older adults (≥60 years) occurred around 6,000–8,000 steps; in younger adults below 60, around 8,000–10,000 steps. Cadence in the peak 30-minute window was independently associated with lower mortality after adjustment for total step count.

Lee 2019 (JAMA Intern Med, n=16,741 older women, Women’s Health Study): Women averaging 4,400 steps per day had 41% lower mortality than those averaging 2,700 steps per day. The benefit plateaued at approximately 7,500 steps per day — providing an anchor for the 60–79 age-band target.

Stamatakis 2022 (Nature Medicine, n=25,241 non-exercisers): Three to four minutes per day of wearable-detected VILPA in one-minute bouts — equivalent to brisk stair climbing or rapid-pace errand walking — reduced all-cause mortality by 38–40%.

Master 2022 (Nature Medicine, n=78,500 UK Biobank): Brisk-cadence walking dose-dependently reduced incidence of 13 chronic diseases including type 2 diabetes, obstructive sleep apnoea, and gastro-oesophageal reflux disease.

Bravata 2007 (JAMA): Pedometer use combined with a step target increased daily walking by ~2,000 steps and reduced systolic blood pressure — supporting the practical value of a numerical target with a step counter.

Does 10,000 steps have any evidence behind it?

The 10,000-step target is not evidence-based in origin, but it is not harmful as a stretch goal for adults under 60 in good health. The key evidence-based takeaway is that the dose-response curve is steepest at the low end: going from 2,000 to 5,000 steps per day delivers more mortality benefit per additional step than going from 9,000 to 12,000. Framing walking targets as achievable increments from current baseline — rather than as a fixed ceiling most people fail to reach — is likely to support better adherence.

Does brisk walking improve cognition?

The Erickson 2011 PNAS trial demonstrated hippocampal volume gain and spatial memory improvement with 40 minutes of brisk walking three times per week over one year in sedentary older adults. This finding is biologically plausible — brain-derived neurotrophic factor (BDNF) secretion is upregulated by aerobic exercise and drives hippocampal neurogenesis. Walking in natural environments appears to amplify cognitive and mood benefits per Twohig-Bennett & Jones 2018, supporting the use of greenspace routes where available.

C. Prescribing walking — practical approach for Australian general practice

The consultation conversation

Start with a week of baseline measurement using whatever wearable or pedometer the patient already has. A realistic stretch goal is 1,000–2,000 steps above their current weekly average — not the abstract 10,000-step ceiling. Negotiate the target, acknowledge barriers (weather, safety, musculoskeletal pain, motivation, time), and make a plan.

For brisk-cadence guidance: suggest one 30-minute purposeful walk daily aiming for 100 steps per minute, using the music or talk-test method. For patients who struggle to carve out 30 continuous minutes, three 10-minute brisk walks achieve a similar aerobic stimulus. Add VILPA by default — take the stairs, park further, walk quickly between tasks.

Integration with chronic conditions:

Hypertension: Regular brisk walking lowers systolic blood pressure by 3–5 mmHg in aggregate — a meaningful contribution that does not substitute medication but complements it
Type 2 diabetes: Post-meal “metabolic walks” of 10–15 minutes lower the postprandial glucose peak by approximately 10–20% — a useful practical strategy for glucose management alongside medication
Depression and anxiety: Walking is an evidence-based adjunct in mild-to-moderate presentations, incorporated within a Mental Health Care Plan (items 2715, 2717) through behavioural activation
Dementia prevention: Regular moderate-intensity walking is one of the most robust modifiable risk-reduction strategies, supported by the Erickson hippocampal evidence and observational cohort data

Monitoring and progressive overload

Re-measure step count at four and twelve weeks. Adjust the target based on progress, address adherence barriers, and apply the 10% rule — avoid increasing weekly walking volume by more than 10% per week to reduce overuse injury risk. A de-load week at roughly 70% of peak volume every four to six weeks supports sustainable progression.

Medications affecting walking prescription:

Beta-blockers: Lower maximum heart rate by 10–25 bpm. Use cadence and the talk test rather than heart rate to gauge intensity
GLP-1 receptor agonists or tirzepatide: Caloric deficit and potential sarcopenia risk — pair with adequate walking and resistance training and ensure protein intake of at least 1.2–1.5 g/kg/day
Sulfonylureas or insulin: Hypoglycaemia risk on prolonged or fasted walks — carry rapid carbohydrate

D. Australian operations

Standard GP consultations (MBS items 23, 36, 44) cover physical activity counselling and exercise prescription. The GP Chronic Condition Management Plan (items 965 and 967, replacing GPMP/TCA since 1 July 2025) gates referral to an accredited exercise physiologist (item 10953) or physiotherapist (item 10960) — up to five allied-health visits per year, shared across disciplines. The Heart Health Check (items 699 and 177 telehealth) for adults aged 45–79 (30+ for Aboriginal and Torres Strait Islander people) includes structured physical-activity assessment and counselling as a core component.

The 75+ health assessment (item 705) includes mandatory functional assessment covering gait speed and falls risk — an appropriate moment to review walking capacity and targets in older adults. The ATSI health assessment (item 715) includes physical activity assessment at any age.

AU walking programs:

Heart Foundation Walking: Australia’s largest free walking network with over 1,000 volunteer walk organisers. Group walks are searchable by suburb, day, pace, and accessibility (wheelchair- and dog-friendly options). Provides templated personal walking plans.
parkrun Australia: 500+ free Saturday-morning 5 km timed events with no time limit; a welcoming culture for walkers. One-off online registration.
10,000 Steps (CQUniversity): Free online tracker funded by Health and Wellbeing Queensland; syncs with Fitbit, Garmin, Apple Health, and Google Fit; supports workplace and community step challenges.

DVA and NDIS: Veterans with gold or white cards access exercise physiology and physiotherapy under D904 referral without an annual cap — well-suited to supervised walking-based reconditioning. NDIS participants may access exercise physiology under the Capacity Building — Improved Health and Wellbeing line where walking supports mobility and independence goals.

Cardiac rehabilitation Phase III: Community walking maintenance is delivered by ESSA-accredited exercise physiologists through the Heart Foundation’s cardiac services directory, accessible under GPCCMP referral (item 10953).

E. Special populations

Older adults and falls: For adults over 65, brisk walking should be paired with strength and balance training — evidence shows that walking alone does not adequately reduce falls risk. The Heart Foundation Walking groups offer pace-matched options and are often a safer and more social walking context than solo outdoor walking. Nordic poles reduce the risk of tripping on uneven terrain and increase energy expenditure by approximately 20%.

People with chronic musculoskeletal conditions: Osteoarthritis of the knee or hip is not a contraindication to walking — low-impact movement reduces pain and disability. Begin at comfortable pace and volume, increase by the 10% rule, and refer to physiotherapy or an accredited exercise physiologist under the GPCCMP for exercise progression in moderate-to-severe arthritis.

Post-cardiac event: After myocardial infarction, heart failure, or major cardiac surgery, walking-based cardiac rehabilitation (Phases II and III) is the evidence-based standard. Begin with short flat walks, progress under AEP supervision, and monitor for exertional symptoms (chest discomfort, unusual dyspnoea, palpitations). Most patients can progress safely to 30–45 minutes of continuous brisk walking within 8–12 weeks of a cardiac event.

Aboriginal and Torres Strait Islander Australians: Culturally safe walking groups facilitated by Aboriginal Community-Controlled Health Services and on-Country walking programs connect physical activity with country, culture, and community — supporting both physical and social-emotional wellbeing. Physical activity counselling via item 715 provides a funded entry point.

People living with disability: NDIS participants may access walking-based reconditioning and exercise physiology. For those with mobility impairments, aquatic walking (hydrotherapy) and supported walking programs adapt the dose to functional capacity.

When to escalate

Stop walking and seek urgent assessment (000 or ED) for:

Central chest pain, jaw pain, or left-arm pain during or immediately after walking — possible acute coronary syndrome
Syncope or near-syncope during exercise
New or worsening dyspnoea on minimal exertion
Sustained palpitations with dizziness or presyncope
Unilateral calf pain and swelling after a walk — possible deep vein thrombosis

Stop and seek same-day GP review for:

A new irregular pulse detected on a wearable
Foot ulcer or new wound in a person with diabetes
Persistent joint pain that worsens session-to-session

Telephone advice is available through HealthDirect 1800 022 222.

What this article is and is not

This article draws on the Paluch 2022 Lancet Public Health meta-analysis, Stamatakis 2022 Nature Medicine VILPA data, the AU 24-Hour Movement Guidelines (2026), Heart Foundation Walking, and related evidence sources. It is general patient information, not personalised medical advice, and does not create a doctor–patient relationship. If you have a cardiac condition, significant musculoskeletal impairment, or are uncertain about safe exercise intensity, discuss your walking goals with your GP before starting or escalating.

For Australian consumer resources: HealthDirect — Physical activity, Better Health Channel — Walking for good health, Heart Foundation Walking, parkrun Australia, 10,000 Steps.

Sources cited

Frequently asked questions

Is the 10,000-steps-per-day target based on evidence?

Not originally. The number comes from a 1965 Japanese pedometer marketed as 'manpo-kei' (10,000-step meter) — a commercial name, not a clinical trial result. Research has since shown that mortality benefit increases steeply from low baselines and levels off at an age-dependent ceiling: around 6,000–8,000 steps per day for adults over 60, and 8,000–10,000 for adults under 60, per a 2022 Lancet Public Health meta-analysis of 47,471 people across 15 cohorts. That said, 10,000 makes a reasonable stretch goal for younger adults. The key message is that any increase from a sedentary baseline produces benefit — you do not need to reach 10,000 before the walking counts.
Does walking speed matter or is total step count all that matters?

Both matter independently. Step volume drives most of the benefit, but cadence — walking speed — adds additional cardiovascular gain beyond what step count alone predicts. Walking at or above 100 steps per minute corresponds to moderate-intensity exercise and appears to independently lower mortality and chronic-disease risk. Practically, this means aiming for at least one 30-minute brisk walk daily (where you can speak in sentences but not sing comfortably) in addition to accumulating total daily steps. Brisk short bouts — stairs, rapid laps, a brisk walk between tasks — also count and have been shown to meaningfully reduce mortality in non-exercising adults.
What step target is right for an older adult?

For adults aged 60–79, the evidence suggests a target of 6,000–8,000 steps per day, with a brisk cadence where tolerated. For adults aged 80 and over, or for frail individuals, 4,000–6,000 steps per day still provides mortality benefit, and the focus shifts more toward safety and balance than speed. The Australian 24-Hour Movement Guidelines (updated 2026) recommend 7,000 steps per day as a trackable target for most adults. For older adults at falls risk, it is important to pair walking with strength and balance training — brisk walking alone does not reduce falls risk as effectively as combined exercise.
Can walking help with depression or anxiety?

Yes — moderate-intensity walking has clinically meaningful effects on mood and anxiety. Aerobic exercise including brisk walking is recommended as an adjunct treatment for mild-to-moderate depression and anxiety in Australian general practice guidelines. The mechanism involves BDNF-driven neurogenesis, improved sleep, reduced inflammatory markers, and psychosocial benefits from getting outdoors and interacting with others. Walking in greenspace (parks, bushland, waterways) appears to amplify the mood effect compared with urban footpaths. A mental health care plan (MBS items 2715 and 2717) can include referral to a psychologist who incorporates behavioural activation — structured, supported walking as part of depression management.
Are there situations when walking should be limited or avoided?

Yes. Walking should be deferred or limited in unstable coronary artery disease, decompensated heart failure, unstable arrhythmias, active DVT, recent pulmonary embolism, severe peripheral arterial disease with rest pain, a febrile illness, or a significant acute musculoskeletal injury limiting gait. For anyone with a recently diagnosed cardiac condition, a confirmed arrhythmia, or exertional symptoms such as chest tightness or dizziness, a GP review before resuming or escalating walking is appropriate. During flu or COVID-19 illness, rest for the acute phase and return gradually — there is a theoretical risk of myocarditis with high-intensity exercise within two to four weeks of systemic viral illness.
How can I track steps accurately and which apps or devices work?

Modern wrist-worn devices — Apple Watch, Garmin, Fitbit — are validated within approximately 5–10% accuracy at normal walking speeds and are the most practical option for most people. Smartphone step-counting apps (Apple Health, Google Fit, Samsung Health) work when the phone is on your person but may undercount if it stays in a bag. Manual pedometers clipped to the waistband are accurate within 5–10% and cost as little as AU$15–40, making them useful for older adults or those without smartphones. Research-grade waist accelerometers are the reference standard used in the major studies but are not available clinically. For frail older adults or those with shuffle gaits, wrist devices may overcount or undercount — a waist-clip pedometer is more reliable in this group.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.